Notice Regarding the Recognition of Non-Operating Income, Non-Operating Expenses and Extraordinary Loss
Perseus Proteomics Inc. (filing company)
The company's fixed assets
The impairment of fixed assets was recognized in accordance with the Accounting Standard for Impairment of Fixed Assets. The specific causes of the individual non-operating income and non-operating expense items were not disclosed.
Grant income: ¥53.311 million (non-operating income); foreign exchange gains: ¥13.835 million (non-operating income); interest income: ¥5.044 million (non-operating income); share acquisition rights issuance costs: ¥6.040 million (non-operating expenses); impairment loss: ¥37.260 million (extraordinary loss)
Cumulative period of the fiscal year ending March 2026
Reflected in the "Summary of Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Non-consolidated)" released today.
| Item | Details |
|---|---|
| Event name | Notice Regarding the Recognition of Non-Operating Income, Non-Operating Expenses and Extraordinary Loss |
| Subject Entity | Perseus Proteomics Inc. (filing company) |
| Target Locations / Products | The company's fixed assets |
| Cause | The impairment of fixed assets was recognized in accordance with the Accounting Standard for Impairment of Fixed Assets. The specific causes of the individual non-operating income and non-operating expense items were not disclosed. |
| Amount of Impact on Business Performance | Grant income: ¥53.311 million (non-operating income); foreign exchange gains: ¥13.835 million (non-operating income); interest income: ¥5.044 million (non-operating income); share acquisition rights issuance costs: ¥6.040 million (non-operating expenses); impairment loss: ¥37.260 million (extraordinary loss) |
| Accounting period in which recognized | Cumulative period of the fiscal year ending March 2026 |
| Impact on Earnings Forecast | Reflected in the "Summary of Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Non-consolidated)" released today. |
Items this document does not state (18)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Grant income, foreign exchange gains and interest income were recognized as non-operating income, while share acquisition rights issuance costs were recognized as non-operating expenses. An impairment loss on fixed assets was recognized in accordance with the Accounting Standard for Impairment of Fixed Assets.